# Inhaled Iloprost, Dynamic Hyperinflation, and Oxidative Stress in COPD Patients

> **NCT01941225** · PHASE2 · COMPLETED · sponsor: **Louisiana State University Health Sciences Center in New Orleans** · enrollment: 24 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Inhaled iloprost 5.0 mcg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01941225
- **Lead sponsor:** Louisiana State University Health Sciences Center in New Orleans
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01941225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01941225, "Inhaled Iloprost, Dynamic Hyperinflation, and Oxidative Stress in COPD Patients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01941225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*